The A1C Shame Spiral
A new type 2 diabetes diagnosis is not a character verdict. Why the A1C shame spiral starts, what actually drives diabetes, and the first steps that help.
Educational content — see our editorial standards.
Metabolic HealthReal shit: the notification that rearranged your life showed up during the 10 a.m. status meeting, wedged between a slide about Q3 pipeline and a guy named Trevor sharing the wrong screen. Your lab results are ready. You opened the portal under the conference table like a teenager checking a text, and there it was — a number with a decimal point and a small red flag beside it, sitting in a row labeled A1C. You spent the next fifty minutes nodding at slides you could not see. Someone asked if the timeline worked for you. You said "makes sense to me" about a timeline that could have been a soup recipe.
Here is the part nobody warns you about. The number did not feel like information. It felt like a verdict read aloud in an empty courtroom where you were the defendant, the jury, and the stenographer writing it all down for later use against yourself. Diagnosis, conviction, sentencing — all between agenda items, no recess. You drove home that night rehearsing how to tell your wife in a voice that would not scare her, and you never quite found the voice, so you told the steering wheel instead.
If some version of that is you, keep reading, because the spiral you are in has a design, and the design can be broken.
And one thing belongs up front, not buried: treatment for type 2 diabetes has genuinely changed in the past few years, and peptide-based prescription medicines — GLP-1 receptor agonists and their newer dual-agonist cousins — are a large part of why. They are tools with real trial evidence behind them, not willpower replacements, and they have changed what care can look like for a lot of men holding a number like yours. If you like to read before you sit across from a prescriber, start with how peptide-based medicines actually fit into diabetes care; the full, honest breakdown — including what these medicines do not do — is further down this page.
The thing you say out loud is not the thing
Ask a newly diagnosed man how he is doing and he hands you logistics. "Sugar's a little high. Cutting back on beer, watching the carbs. My dad had it. It's basically maintenance." Maintenance — like you are a truck that needs its brakes looked at. The word does useful work, because it keeps the whole conversation in the garage and out of the confessional.
But at 11:30 p.m., alone with the fridge light, the real sentence surfaces, and it is not about carbohydrates. It is: I did this to myself. Every burger becomes evidence. Every skipped workout gets subpoenaed. The A1C stops being what it actually is — a running three-month average of blood sugar, a gauge — and becomes a grade on your character, stapled to your file, visible, you are convinced, to your doctor, your wife, and every man at the gym who still has a working pancreas.
That is the spiral. Not the diabetes. The story about the diabetes.
The shame machine runs on one fuel
Here is your actual enemy, and it is not dessert. It is the cultural story that type 2 diabetes has exactly one cause — moral weakness — and therefore exactly one meaning: you failed. That story is everywhere. It is in decades of finger-wagging public health messaging. It is in every comedian's cheap joke. It is in the way people say "lifestyle disease" with their eyebrows.
It is also factually wrong. Type 2 diabetes develops through a pile-up of interacting factors: genetics and family history, age, body composition, certain medications, sleep debt, chronic stress physiology, income and work schedules that decide what food and rest are even available, and the underlying biology of insulin resistance — which does not check your character references before it moves in. Some of those factors were never in your hands. A man can do many things right and still watch that number climb, and a man can do plenty wrong and coast for decades. Biology is not a courtroom, no matter how hard you keep trying to hold trial.
Does a high A1C mean you caused your type 2 diabetes? No. An A1C reflects your average blood sugar over roughly three months — it measures biology, not character. Type 2 diabetes develops from many interacting factors, including genetics, age, medications, sleep, stress, and body composition, several of which are outside anyone's direct control. A lab value is a starting point for care, not a moral verdict.
And here is the practical problem with shame, beyond the fact that it feels like swallowing a hot coal: it is a terrible fuel. Shame drives men to hide the glucose meter in a sock drawer, cancel the follow-up, and go dark on the exact people who could help. The story that was supposed to motivate you is the thing keeping you stuck in the parking lot.
The Baseline Audit
Stop guessing what changed.
Ten questions on energy, sleep, weight, libido, recovery, stress, and goals — about three minutes. Then use the read to decide what to raise with a qualified clinician.
Take the Baseline AuditWhat to do in the first thirty days (none of it is penance)
The reframe is simple and it is not soft. Here is what to do with the gauge you were handed.
First, make your doctor translate the numbers to you, specifically. Not the pamphlet version. Say this, word for word: "Can you walk me through what my A1C and fasting glucose mean for me specifically, what target we're aiming for, and why that target?" You are allowed to ask twice. A number you understand is a tool; a number you fear is a ghost.
Second, ask what rides along with it. Blood pressure, cholesterol, kidney function, sleep apnea screening if you snore like a wood chipper. Type 2 rarely travels alone, and the passengers matter as much as the driver.
Third, get a referral to diabetes education. Ask specifically: "Can you refer me to a certified diabetes care and education specialist?" This is a real profession, often covered by insurance, and it exists so you do not have to reverse-engineer your own care from search results at midnight.
Fourth, change one food pattern, not your entire identity. The men who torch the whole menu in week one are usually eating penance, not dinner, and penance has a short shelf life. Pick the single highest-traffic pattern — the 9 p.m. pantry loop, the gas-station lunch — and rebuild that one.
Fifth, walk after your biggest meal. Ten to fifteen minutes, most days. Not because a walk is a magic spell, but because movement after eating is one of the cheapest levers you own, and because it gives the evening a spine.
Sixth, tell one person the truth. Not the maintenance version. The real one: "I got diagnosed with type 2 diabetes and it scared the hell out of me." Watch what happens to the weight of it the first time it leaves your body through your mouth instead of circling your skull at 2 a.m.
Seventh, name the shame reflex when it fires. You will hear I did this to myself again — probably this week. You do not have to argue with it. Just label it: that is the story, not the data. Then go read the actual gauge.
You did not get a verdict. You got a gauge, and a gauge is the beginning of leverage.
Where peptide-based medicine fits — and where it doesn't
As promised, the straight version. GLP-1 receptor agonists — and the newer dual GIP/GLP-1 receptor agonists — are peptide-based prescription drugs, FDA-approved for specific indications: improving blood sugar control in adults with type 2 diabetes and, for certain products, chronic weight management. The evidence base is not vibes; it is large randomized trials showing meaningful A1C improvement and, for many patients, substantial weight loss. In practice they are commonly prescribed as a weekly treatment under a prescriber, often alongside other diabetes medicines such as metformin, with the plan adjusted over time based on your labs and your response.
Why men your age are interested is no mystery: for eligible patients, these medicines can take real pressure off the two numbers — glucose and weight — that drive most of the type 2 conversation. The limits, stated as facts rather than fine print: side effects are real, most commonly stomach and GI effects during the adjustment period; results vary between people; weight regain after stopping is common; and none of it substitutes for food you can live with, sleep, movement, or the mental side of this condition. Whether one fits you is an eligibility question — your history, contraindication screening, monitoring over time — that only you and a licensed prescriber can settle.
One market note worth keeping: compounded versions of these drugs are not FDA-approved products and quality varies widely — know exactly what you are being offered, and by whom, before anything goes in your body.
Six months from now, on a Tuesday
Here is the believable version of better — not a transformation ad, a Tuesday. The portal pings during a meeting and your stomach does not drop, because you know what the number was last quarter and what you and your doctor changed since. There is a pair of walking shoes by the back door with actual wear on them. Dinner is food you chose on purpose, not a sentence you are serving. Your wife knows the real number, and the silence in the truck is just silence now, not a courtroom.
The diagnosis stays. The verdict goes. That trade is available, and it starts with reading the gauge instead of prosecuting the driver.
Learn before you leap
Peptide-based medicines are prescription tools for specific patients, not absolution and not a shortcut around care. Read the evidence before you shop the market, ask your prescriber the eligibility question directly, and never use research products for self-treatment.
Sources
- Diabetes — Centers for Disease Control and Prevention
- Type 2 diabetes health information — NIDDK (NIH)
- Diabetes Type 2 — MedlinePlus (NIH)
- Standards of Care in Diabetes — American Diabetes Association
- Human Drug Compounding — U.S. Food and Drug Administration
This article is educational and is not medical advice. If you are dealing with libido changes, ED, blood sugar concerns, hair loss, weight gain, pain, or recovery issues, talk with a qualified clinician before starting any treatment. See our editorial standards.
Byline
Ray Santos
Metabolic Health Writer
Covers blood sugar, weight maintenance, labs, energy, and the health signals men avoid until they get loud.
More from Ray Santos →The Second Half Brief
More on metabolic health, weekly.
One raw email a week — no spam, no miracle claims. Or see what the Brief is.
Write to us
Letters from the Bench
Been through a version of this? Reply with your story and we may run it in a future Letters from the Bench feature. Nothing gets published without your explicit permission, and anything we run is anonymized.
Send your story




